GAYLE FUNK: Open Payments
NPI 1114167830 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 39 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $161 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Janssen Biotech, Inc. | 3 | $89 |
| ABBVIE INC. | 3 | $73 |
| GENZYME CORPORATION | 2 | $58 |
| Incyte Corporation | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Tempus AI, Inc | 1 | $30 |
Products named: LIBTAYO, Enhertu, KISQALI, WAYRILZ, DARZALEX, IMFINZI, ERLEADA, XT CDX.
Industry payments across WA — which companies pay providers there.
